According to a recent industry report by Fortune Business Insights, the global hernia mesh devices market is projected to witness steady growth over the coming years, driven by the rising prevalence of hernia-related disorders, increasing adoption of minimally invasive surgeries, and innovations in mesh technology. The market size is expected to grow significantly, supported by the rising number of surgical procedures, improvements in reimbursement policies, and growing demand for lightweight, biocompatible mesh products. Additionally, the growing geriatric population and increasing awareness regarding early hernia treatment are further propelling market expansion.
According to Fortune Business Insights, the hernia mesh devices market was valued at USD 2.29 billion in 2024. It is projected to grow from USD 2.40 billion in 2025 to USD 3.76 billion by 2032, exhibiting a CAGR of 6.6% during the forecast period. In 2024, North America led the hernia mesh devices market with a share of 35.37%.
In December 2022, W. L. Gore & Associates announced a strategic partnership with AGC Biologics to implement protein A-based purification technology. This collaboration aims to reduce both the manufacturing footprint and the clinical production cost of hernia mesh products, indicating a shift toward streamlined, cost-effective production processes.